NBP Stock Summary and Trading Ideas (Novabridge Biosciences - American Depositary Shares | NASDAQ:NBP)

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Novabridge Biosciences - American Depositary Shares trades on the NASDAQ stock market under the symbol NBP.

As of November 6, 2026, NBP stock price was flat at $0.91 with 400,709 million shares trading.

NBP has a beta of 0.95, meaning it tends to be less sensitive to market movements. NBP has a correlation of 0.03 to the broad based SPY ETF.

NBP has a market cap of $104.83 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that NBP belongs to (by Net Assets): IBB, SPEM, SBIO, QQQS, GXC.

NBP has underperformed the market in the last year with a price return of -78.7% while the SPY ETF gained +9.6%. NBP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -44.5% and -31.6%, respectively, while the SPY returned -4.2% and -3.8%, respectively.

NBP support price is $.86 and resistance is $.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NBP shares will trade within this expected range on the day.